First Time Loading...

Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 35.68 USD -2.73% Market Closed
Updated: Jun 1, 2024

Rhythm Pharmaceuticals Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rhythm Pharmaceuticals Inc
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Other Current Liabilities
$11.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$3.3B
CAGR 3-Years
149%
CAGR 5-Years
406%
CAGR 10-Years
26%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$648.6m
CAGR 3-Years
32%
CAGR 5-Years
8%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$516.7m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
23%

See Also

What is Rhythm Pharmaceuticals Inc's Other Current Liabilities?
Other Current Liabilities
11.4m USD

Based on the financial report for Mar 31, 2024, Rhythm Pharmaceuticals Inc's Other Current Liabilities amounts to 11.4m USD.

What is Rhythm Pharmaceuticals Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 1Y
101%

Over the last year, the Other Current Liabilities growth was 101%.